About Dr. Adam

Dr. Adam

I am a board-certified psychiatrist who works closely with adults seeking clarity, balance, and a renewed sense of well-being. My approach is collaborative and discreet, blending thoughtful medication management with supportive psychotherapy. I’ve cared for patients in a wide range of settings, from academic medical centers to private practice, and I believe the most meaningful results come from a personalized and steady partnership.

Dr. Tarek Adam

Training & Background

Education

Clinical Experience

Licensure & Certification

New York & California – Board Certified, ABPN.

Publications & Research

My academic work has focused on psychopharmacology, neuroscience, and data-driven health outcomes. I've authored and coauthored publications in both clinical and translational psychiatry, including a textbook chapter for the American Psychiatric Association Publishing Textbook of Psychiatry.

Selected Publications:

Avery J, Adam T, Leounis P. Substance-Related and Addictive Disorders. In: Roberts LW, ed. The American Psychiatric Association Publishing Textbook of Psychiatry, 7th ed. Washington, DC: APA Publishing; 2019.

Mermelstein AC, Mermelstein J, Adam T, Brody BD, Dubin MJ. Oxcarbazepine-induced liver injury after sensitization by valproic acid: a case report. Bipolar Disorders. 2016;18(13):307-309.

Schmidt S, Schenková K, Adam T, Erikson E, Lehmann-Koch J, Sertel S, Verhasselt B, Fackler OT, Keppler OT. SAMHD’s protein expression profile in humans. Journal of Leukocyte Biology. 2015;98(1):5-14.

Erikson E, Adam T, Schmidt S, Lehmann-Koch J, Over B, Goffinet C, et al. In vivo expression profile of the antiviral restriction factor and tumor-targeting antigen CD317/BST-2/HM1.24/tetherin in humans. PNAS.2011;108(33):13688-13693.

Ghosh D, Cabrera J, Adam TN, Leounis P, Adam N. Comorbidity patterns and their impact on health outcomes: two-way clustering analysis. IEEE Transactions on Big Data. 2020;6(2):359-368.

Frequently Asked Questions

Do you offer telepsychiatry?

Yes. All appointments are provided remotely via a secure, HIPAA-compliant video platform.

Where are you licensed to practice?

I am licensed in New York and California and can only see patients who are physically located in those states at the time of the appointment.

What happens during the first appointment?

The initial evaluation lasts 60–90 minutes. We will review your history, current concerns, and goals, then discuss psychotherapy and, if appropriate, medication treatment options.

Are you accepting new patients?

Yes. I am currently accepting new patients.

Do you take insurance?

I take Aetna insurance through Headway. For out of network/private pay patients I can provide a receipt (“superbill”) that you may submit to your insurance if you have out-of-network benefits.

What is your cancellation policy?

Cancellations or rescheduling must be made at least 48 hours in advance to avoid a full session fee.

How long are follow-up appointments?

Follow-up sessions are typically 30 or 45 minutes, depending on your needs and the treatment plan we establish.

Our Treatment Promise

We promise to be accepting of your needs and your goals, be responsive and accessible to you, and will ensure you have a clear understanding of your treatment plan.
Every patient is unique and receives an evaluation and treatment options specifically tailored to their specific needs.